Connection

VALERAE O LEWIS to Cell Line, Tumor

This is a "connection" page, showing publications VALERAE O LEWIS has written about Cell Line, Tumor.
Connection Strength

0.122
  1. BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation. Proc Natl Acad Sci U S A. 2017 07 25; 114(30):8065-8070.
    View in: PubMed
    Score: 0.050
  2. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res. 2009 Mar 01; 69(5):1995-9.
    View in: PubMed
    Score: 0.028
  3. BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression. Cancer Lett. 2024 Aug 01; 596:217009.
    View in: PubMed
    Score: 0.020
  4. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia. 2018 01; 20(1):32-43.
    View in: PubMed
    Score: 0.013
  5. Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings. Anticancer Res. 2017 09; 37(9):4727-4732.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.